Following a lackluster 2024, shares of major drug markers kicked off 2025 with an upbeat quarterly results reading.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Iovance Biotherapeutics (IOVA – Research ...

She's an Upstate interior designer, he is a passionate golfer. Their Downtown Greenville condo was designed for a new ...

Vogue Williams and Spencer Matthews are selling their luxurious £4.7million London pad - which has had its price slashed from ...

Cory Wendel is ready to show off his new location of Lachele's Fine Foods with fried chicken, hot beef sandwiches and only 3 ...

Netflix's strategic shifts and global expansion drive profitability and value, with a bold $1500+ stock target in 12-18 ...